ME
Memphasys Limited
MEM.AX · ASX
$0.01 +0.00% (+$0.00)
1M +0.00%
Market Cap $18.5M
P/E Ratio -
Div. Yield -
ROE 83.41%
Piotroski F-Score Moderate
4/9Valuation
23 /100
Expensive P/S 67.65x
P/B 4.40x
P/E N/A
Growth
78 /100
Growing Rev. growth 161.16%
Book val. growth 17.06%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 556.14%
Net margin 1,498.73%
Op. margin 1,516.75%
Quality
0 /100
Poor ROIC 49.08%
ROE 83.41%
ROA 36.52%
Debt
23 /100
High Debt/Equity 1.01x
Current ratio 0.31x
Int. coverage -10.82x
Stability
39 /100
Moderate Beta 0.46x
Rev. volatility 415.37%
EPS volatility 26.21%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEM.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
R. John Aitken
Employees
24
Headquarters
Homebush